028300 — HLB Share News
0.000.00%
Last trade - 00:00- KR₩6tn
- KR₩7tn
- KR₩84bn
Brief: Elevar Therapeutics Resubmits NDA To U.S. FDA For Camrelizumab Plus Rivoceranib Astreatment For Unresectable Hepatocellular Carcinoma
Brief: Hlb Inc To Acquire 16 Billion Won Worth Of Shares In Neurotobe Pharmaceuticals Inc
Health Rounds: Exercise helps with sexual dysfunction after prostate cancer treatment
Brief: HLB Inc Signs 18.5 Billion Won Supply Deal
Brief: HLB Inc Q2 Operating Profit Likely 13 Billion Won, Turns To Profit From Year Earlier
Brief: HLB Acquires Shares Worth 10 Mln Dollars In LSK Biopartners In U.S.
Brief: HLB raises 19 bln won in private placement
Brief: HLB issues 30th series bonds with warrants worth 39.5 bln won
Brief: HLB issues 29th series convertible bonds worth 7 bln won
Brief: HLB signs contract worth 2.83 bln won
Brief: HLB issues 28th series convertible bonds worth 3 bln won
Brief: HLB says subscription results of 26th series convertible bonds